The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The committee expressed “appreciation for WHO and partners’ COVID-19 pandemic response efforts, and highlighted the anticipated lengthy duration of ...
read more
The FDA has taken steps to encourage the development of tests for screening asymptomatic individuals and for testing pooled samples.
read more
The FDA has broadened the scope of the existing EUA for remdesivir to include treatment of all hospitalized patients with COVID-19.
read more
Thursday, September 03, 2020
ADMA Biologics announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA.
read more
Thursday, September 10, 2020
AstraZeneca Pharmaceuticals
A standard review process has been triggered, leading to the voluntary pause of all COVID-19 vaccination trials.
read more
Thursday, September 10, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Tuesday, September 15, 2020
AstraZeneca Pharmaceuticals
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the MHRA that it was safe to...
read more
Thursday, September 24, 2020
MorphoSys and I-Mab announced the FDA has cleared the IND for antibody MOR210/TJ210 for relapsed or refractory advanced solid tumors.
read more
Tuesday, September 29, 2020
Eiger announced results of an investigator sponsored study of Peginterferon Lambda-1a in outpatients with mild and uncomplicated COVID-19.
read more
Wednesday, September 30, 2020
Leinco has developed a proprietary, fully validated assay termed COVID-19 ImmunoRank Neutralization MICRO-ELISA test.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Tuesday, October 13, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Novellus has licensed its induced mesenchymal stem cells on a worldwide basis to NoveCite, a newly formed subsidiary of Citius Pharmaceuticals.
read more
Thursday, October 22, 2020
Centogene announced the FDA has issued EUA for CentoSure, the company's latest SARS-CoV-2 RT-PCR test.
read more
Thursday, October 22, 2020
DxTerity Diagnostics announced the EUA for their SARS-CoV-2 RT-PCR test, SafeWorkDx.
read more